Human serum albumin-polyethylenimine nanoparticles for gene delivery

Journal of Controlled Release

Volumn 92, Issue 1-2, 2003, Pages 199-208

  Rhaese, Stephanie ^a   Von Briesen, Hagen ^b   Rübsamen Waigmann, Helga ^c   Kreuter, Jörg ^a   Langer, Klaus ^a  

^a GOETHE UNIVERSITY   (Germany)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

^c BAYER AG   (Germany)

Author keywords

Gene delivery; Human serum albumin; Nanoparticles

Indexed keywords

DNA; GENES; NANOSTRUCTURED MATERIALS; SPECTROPHOTOMETRY;

GENE DELIVERY;

PROTEINS;

DNA; HUMAN SERUM ALBUMIN; NANOPARTICLE; POLYETHYLENEIMINE;

ARTICLE; CYTOTOXICITY; EMBRYO CELL; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; KIDNEY EPITHELIUM; LIGHT SCATTERING; PRIORITY JOURNAL; REPORTER GENE;

EID: 0141853247     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(03)00302-X     Document Type: Article

References (36)

1. Verma I.M., Somia N. Gene therapy - promises, problems and prospects. Nature. 389:1997;239-242.
2. Felgner P.L. Nonviral strategies for gene therapy. Sci. Am. 276:1997;102-106.
3. Plank C., Mechtler K., Szoka F.C. Jr., Wagner E. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. Hum. Gene Ther. 7:1996;1437-1446.
4. Chonn A., Semple S.C., Cullis P.R. Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. J. Biol. Chem. 267:1992;18759-18765.
5. Ogris M., Brunner S., Schüller S., Kircheis R., Wagner E. PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery. Gene Ther. 6:1999;595-605.
6. Kreuter J. Evaluation of nanoparticles as drug-delivery systems. II: Comparison of the body distribution of nanoparticles with the body distribution of microspheres (diameter greater than 1 μm), liposomes, and emulsions. Pharm. Acta Helv. 58:1983;217-226.
7. Cohen H., Levy R.J., Gao J., Fishbein I., Kousaev V., Sosnowski S., Slomkowski S., Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther. 7:2000;1896-1905.
8. Luo D., Saltzman W.M. Enhancement of transfection by physical concentration of DNA at the cell surface. Nat. Biotechnol. 18:2000;893-895.
9. Lin W., Coombes A.G., Davies M.C., Davis S.S., Illum L. Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J. Drug Target. 1:1993;237-243.
10. Rubino O.P., Kowalsky R., Swarbrick J. Albumin microspheres as a drug delivery system: relation among turbidity ratio, degree of crosslinking, and drug release. Pharm. Res. 10:1993;1059-1065.
11. Chen C.Q., Lin W., Coombes A.G., Davis S.S., Illum L. Preparation of human serum albumin microspheres by a novel acetone-heat denaturation method. J. Microencapsul. 11:1994;395-407.
12. Orson F.M., Kinsey B.M., Hua P.J., Bhogal B.S., Densmore C.L., Barry M.A. Genetic immunization with lung-targeting macroaggregated polyethyleneimine-albumin conjugates elicits combined systemic and mucosal immune responses. J. Immunol. 164:2000;6313-6321.
13. Orson F.M., Song L., Gautam A., Densmore C.L., Bhogal B.S., Kinsey B.M. Gene delivery to the lung using protein/polyethylenimine/plasmid complexes. Gene Ther. 9:2002;463-471.
14. Simões S., Slepushkin V., Pires P., Gaspar R., Pedroso de Lima M.C., Düzgüneş N. Human serum albumin enhances DNA transfection by lipoplexes and confers resistance to inhibition by serum. Biochim. Biophys. Acta. 1463:2000;459-469.
15. Weber C., Reiss S., Langer K. Preparation of surface modified protein nanoparticles by introduction of sulfhydryl groups. Int. J. Pharm. 211:2000;67-78.
16. Kircheis R., Kichler A., Wallner G., Kursa M., Ogris M., Felzmann T., Buchberger M., Wagner E. Coupling of cell-binding ligands to polyethylenimine for targeted gene delivery. Gene Ther. 4:1997;409-418.
17. Wagner E., Zatloukal K., Cotten M., Kirlappos H., Mechtler K., Curiel D.T., Birnstiel M.L. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc. Natl. Acad. Sci. USA. 89:1992;6099-6103.
18. Ferkol T., Perales J.C., Mularo F., Hanson R.W. Receptor-mediated gene transfer into macrophages. Proc. Natl. Acad. Sci. USA. 93:1996;101-105.
19. Hashida M., Akamatsu K., Nishikawa M., Yamashita F., Takakura Y. Design of polymeric prodrugs of prostaglandin E(1) having galactose residue for hepatocyte targeting. J. Control. Release. 62:1999;253-262.
20. Nishikawa M., Takemura S., Yamashita F., Takakura Y., Meijer D.K., Hashida M., Swart P.J. Pharmacokinetics and in vivo gene transfer of plasmid DNA complexed with mannosylated poly(L-lysine) in mice. J. Drug Target. 8:2000;29-38.
21. Ogris M., Steinlein P., Kursa M., Mechtler K., Kircheis R., Wagner E. The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells. Gene Ther. 5:1998;1425-1433.
22. Blessing T., Kursa M., Holzhauser R., Kircheis R., Wagner E. Different strategies for formation of pegylated EGF-conjugated PEI/DNA complexes for targeted gene delivery. Bioconj. Chem. 12:2001;529-537.
23. Kircheis R., Wightman L., Schreiber A., Robitza B., Rössler V., Kursa M., Wagner E. Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther. 8:2001;28-40.
24. Fischer D., Bieber T., Brüsselbach S., Elsässer H., Kissel T. Cationized human serum albumin as a nonviral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency. Int. J. Pharm. 225:2001;97-111.
25. Boussif O., Lezoualc'h F., Zanta M.A., Mergny M.D., Scherman D., Demeneix B., Behr J.P. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. USA. 92:1995;7297-7301.
26. Godbey W.T., Wu K.K., Mikos A.G. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. USA. 96:1999;5177-5181.
27. Katayose S., Kataoka K. Water-soluble polyion complex associates of DNA and poly(ethylene glycol)-poly(L-lysine) block copolymer. Bioconj. Chem. 8:1997;702-707.
28. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
29. Truong-Le V.L., Walsh S.M., Schweibert E., Mao H.Q., Guggino W.B., August J.T., Leong K.W. Gene transfer by DNA-gelatin nanospheres. Arch. Biochem. Biophys. 361:1999;47-56.
30. Langer K., Balthasar S., Vogel V., Dinauer N., von Briesen H. Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 257:2003;169-180.
31. Fischer D., Bieber T., Li Y., Elsässer H.P., Kissel T. A novel nonviral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm. Res. 16:1999;1273-1279.
32. Zuidam N.J., Posthuma G., de Vries E.T., Crommelin D.J., Hennink W.E., Storm G. Effects of physicochemical characteristics of poly(2-(dimethylamino)ethyl methacrylate)-based polyplexes on cellular association and internalization. J. Drug Target. 8:2000;51-66.
33. Wightman L., Kircheis R., Rössler V., Carotta S., Ruzicka R., Kursa M., Wagner E. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J. Gene Med. 3:2001;362-372.
34. Roser M., Fischer D., Kissel T. Surface-modified biodegradable albumin nano- and microspheres. II: effect of surface charges on in vitro phagocytosis and biodistribution in rats. Eur. J. Pharm. Biopharm. 46:1998;255-263.
35. Simões S., Slepushkin V., Pretzer E., Dazin P., Gaspar R., Pedroso de Lima M.C., Düzgüneş N. Transfection of human macrophages by lipoplexes via the combined use of transferrin and pH-sensitive peptides. J. Leukoc. Biol. 65:1999;270-279.
36. Weber C., Coester C., Kreuter J., Langer K. Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 194:2000;91-102.